DekaBank Deutsche Girozentrale
TPST icon

DekaBank Deutsche Girozentrale’s Tempest Therapeutics TPST Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4
Closed -$102K – 1042
2016
Q1 		$102K Buy
+4
New +$84.5K ﹤0.01% 953

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TPST Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Tempest Therapeutics (TPST) in Q2 2016, closing a stake of 4 shares — an estimated $102K sold.

DekaBank Deutsche Girozentrale first reported a position in TPST in Q1 2016 and held it in 1 quarter. The position peaked at $102K in Q1 2016. 85 funds tracked by Wall St. Rank hold TPST as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Tempest Therapeutics position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 4 Tempest Therapeutics shares in Q2 2016, an estimated $102K.
  • DekaBank Deutsche Girozentrale first reported a position in Tempest Therapeutics in Q1 2016 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's Tempest Therapeutics position peaked at $102K in Q1 2016.
  • 85 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.